ELI LILLY AND COMPANY (LLY) - Price, trends, fundamentals and chart - Passport to Wall Street

ELI LILLY AND COMPANY (NYSE: LLY)

Overview

current price

$870.59

$870.59

change

-42.18 | -4.62%

-42.18 | -4.62%

Yesterday's Close

912.76

open

905.39

volume

2.41 M

30d. avg volume.

3.47 M

1 day

861.39 - 908.00

52 weeks

711.40 - 972.53

p/e

77.95

beta

0.3417

market cap

865.45 B

dividend yield

0.66%

Industry

-

News and Commentary

Novo Nordisk Boosts Wegovy Access With Lower Pricing and Home Delivery On Wednesday, Novo Nordisk A/S (

Market Update: Dow Climbs 480 Points on Trump U.S. Auto Tariff Exemption Stocks rose during a volatile session on Wednesday as the broader market partially recovered from two straight sessions of deep losses tied to the start of President Donald Trump...

Pfizer CEO Says Company May Shift Overseas Manufacturing To US Amid Looming Tariff Threats: 'Will Th... In light of potential tariff threats from President Donald Trump, Pfizer Inc.'s

Eli Lilly Expands Zepbound Vial Options, Lowers Prices For 2.5 mg, 5 Mg Doses On Tuesday, Eli Lilly And Co (...

Eli Lilly Q4 Earnings: Strong Demand For Mounjaro But Prices Dip, Forecasts Over 30% Jump In 2025 Sa... On Thursday, Eli Lilly and Co (

Market Update: Dow Falls 100 Points, S&P 500 Gains Ahead of Key Jobs Report Stocks were mixed Thursday as market participants digested another large batch of corporate earnings. The S&P 500 Index and Nasdaq Composite each moved about 0.4% and 0.5% higher...

Market Update: Dow Rises 300 Points as Sentiment Improves Stocks were higher on Wednesday as investor sentiment remained positive even as mega cap tech stocks Alphabet and Advanced Micro Devices fell deeply throughout the session. The D...

Market Update: Dow Climbs 200 Points on Light Wholesale Inflation Reading Stocks rose higher Tuesday as market participants cheered a lighter-than-expected inflation reading ahead of more key economic reports due out later this week. The Dow Jones Indu...

Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drug... On Tuesday, Eli Lilly and Co (...

Eli Lilly Scoops Up Scorpion Therapeutics' Early-Stage Cancer Program For $2.5 Billion On Monday, Eli Lilly And Co (L...

StockTwits

StockTwits